Hyun Ah Yoon
Overview
Explore the profile of Hyun Ah Yoon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
142
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Celikgil A, Massimi A, Nakouzi A, Herrera N, Morano N, Lee J, et al.
PLoS One
. 2023 Feb;
18(2):e0276829.
PMID: 36757919
Antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) target multiple epitopes on different domains of the spike protein, and other SARS-CoV-2 proteins. We developed a SARS-CoV-2 multi-antigen protein microarray...
2.
Park H, Tarpey T, Liu M, Goldfeld K, Wu Y, Wu D, et al.
JAMA Netw Open
. 2022 Jan;
5(1):e2147375.
PMID: 35076698
Importance: Identifying which patients with COVID-19 are likely to benefit from COVID-19 convalescent plasma (CCP) treatment may have a large public health impact. Objective: To develop an index for predicting...
3.
Yoon H, Riska P, Jain R, Morales C, Pirofski L
Med Mycol Case Rep
. 2021 Feb;
32:14-16.
PMID: 33552883
Cryptococcal meningoencephalitis (CM) classically occurs in individuals with advanced HIV infection, solid organ transplants, or other immunocompromising conditions. We report a case of fatal CM in a 78-year-old woman with...
4.
Yoon H, Bartash R, Gendlina I, Rivera J, Nakouzi A, Bortz 3rd R, et al.
JCI Insight
. 2021 Jan;
6(4).
PMID: 33476300
Convalescent plasma with severe acute respiratory disease coronavirus 2 (SARS-CoV-2) antibodies (CCP) may hold promise as a treatment for coronavirus disease 2019 (COVID-19). We compared the mortality and clinical outcome...
5.
Yoon H, Bartash R, Gendlina I, Rivera J, Nakouzi A, Bortz 3rd R, et al.
medRxiv
. 2020 Dec;
PMID: 33300012
Convalescent plasma with severe acute respiratory disease coronavirus 2 (SARS-CoV-2) antibodies (CCP) may hold promise as treatment for Coronavirus Disease 2019 (COVID-19). We compared the mortality and clinical outcome of...
6.
Tymon-Rosario J, Atrio J, Yoon H, Erlichman D, Lerner V
Case Rep Obstet Gynecol
. 2019 Aug;
2019:6491617.
PMID: 31467746
Background: Previous reports have described cases of abscess formation by involving the oral cavity, gastrointestinal tract, and septic thrombophlebitis of the right ovarian vein with subsequent bacteremia and septic shock....
7.
Yoon H, Felsen U, Wang T, Pirofski L
Med Mycol
. 2019 Jul;
58(4):434-443.
PMID: 31342058
Cryptococcus neoformans causes life-threatening meningoencephalitis. Human immunodeficiency virus (HIV) infection is the most significant predisposing condition, but persons with other immunodeficiency states as well as phenotypically normal persons develop cryptococcosis....
8.
Yoon H, Nakouzi A, Chang C, Kuniholm M, Carreno L, Wang T, et al.
J Infect Dis
. 2018 Jul;
219(3):420-428.
PMID: 30010905
Background: Initiation of antiretroviral therapy (ART) in human immunodeficiency virus (HIV)-infected individuals with cryptococcal meningitis places them at risk for Cryptococcus-associated immune reconstitution inflammatory syndrome (C-IRIS). The relationship between antibody...
9.
Yoon H, Noh M, Kim B, Han J, Jang J, Choi S, et al.
World J Gastroenterol
. 2011 Nov;
17(35):4023-30.
PMID: 22046092
Aim: To investigate the role and clinicopathological significance of aberrant expression of Notch receptors and Delta-like ligand-4 (DLL4) in extrahepatic cholangiocarcinoma and gallbladder carcinoma. Methods: One hundred and ten patients...
10.
Woo S, Noh M, Kim B, Hsing C, Han J, Ryu S, et al.
Korean J Gastroenterol
. 2011 Jul;
58(1):31-7.
PMID: 21778801
Background/aims: The aim of this study is to assess serum procalcitonin (PCT) for early prediction of severe acute pancreatitis compared with multiple scoring systems and biomarkers. Methods: Forty-four patients with...